Search Results - "Valéry, Marine"

FGFR2 fusion in metastatic pancreatic ductal adenocarcinoma: Is there hope? by Helal, Clara, Valéry, Marine, Ducreux, Michel, Hollebecque, Antoine, Smolenschi, Cristina

Get full text

Clinical and molecular features of early onset pancreatic adenocarcinoma by Rémond, Maxime, Smolenschi, Cristina, Tarabay, Anthony, Gelli, Maximiliano, Fernandez-de-Sevilla, Elena, Mouawia, Ali, Cosconea, Simona, Tselikas, Lambros, Barbe, Remy, Fuerea, Alina, Bani, Mohamed A, Deloger, Marc, Besse, Benjamin, Pudlarz, Thomas, Valéry, Marine, Boige, Valérie, Hollebecque, Antoine, Ducreux, Michel, Boilève, Alice

“…Pancreatic adenocarcinoma (PDAC) is a major health burden and may become the second cause of death by cancer in developed countries. The incidence of…”
Get full text

KRAS , a New Target for Precision Medicine in Colorectal Cancer? by Boilève, Alice, Smolenschi, Cristina, Lambert, Aurélien, Boige, Valérie, Delaye, Matthieu, Camilleri, Géraldine M, Tarabay, Anthony, Valéry, Marine, Fuerea, Alina, Pudlarz, Thomas, Mathieu, Jacques R R, Jaulin, Fanny, Hollebecque, Antoine, Ducreux, Michel

“…Colorectal cancer (CRC) remains a leading cause of cancer-related mortality globally, with significant public health concerns. This review examines the…”
Get full text

Organoids for Functional Precision Medicine in Advanced Pancreatic Cancer by Boilève, Alice, Cartry, Jérôme, Goudarzi, Negaar, Bedja, Sabrina, Mathieu, Jacques R.R., Bani, Mohamed-Amine, Nicolle, Rémy, Mouawia, Ali, Bouyakoub, Ryme, Nicotra, Claudio, Ngo-Camus, Maud, Job, Bastien, Lipson, Karélia, Boige, Valérie, Valéry, Marine, Tarabay, Anthony, Dartigues, Peggy, Tselikas, Lambros, de Baere, Thierry, Italiano, Antoine, Cosconea, Simona, Gelli, Maximiliano, Fernandez-de-Sevilla, Elena, Annereau, Maxime, Malka, David, Smolenschi, Cristina, Ducreux, Michel, Hollebecque, Antoine, Jaulin, Fanny

“…Patient-derived organoids (PDOs) are promising tumor avatars that could enable ex vivo drug tests to personalize patients’ treatments in the frame of…”
Get full text

Rechallenge After Oxaliplatin-Induced Hypersensitivity Reactions by Rassy, Elie, Le Roy, Florence, Smolenschi, Cristina, Valéry, Marine, Boige, Valérie, Ducreux, Michel, Boilève, Alice

Get more information

Oxaliplatin-induced peripheral neuropathy with hepatic arterial versus intravenous infusion in metastatic colorectal cancer by Valéry, Marine, Tanguy, Marie-Laure, Gelli, Maximiliano, Smolenschi, Cristina, Hollebecque, Antoine, Boilève, Alice, de Sevilla, Elena Fernandez, Tselikas, Lambros, Bonnet, Baptiste, Goéré, Diane, Taïeb, Julien, Boige, Valérie, Ducreux, Michel, Malka, David

“…Background Oxaliplatin, a major drug in metastatic colorectal cancer (mCRC), is responsible for cumulative, dose-limiting peripheral neuropathy (PN). Whether…”
Get full text

Automated Detection of Natural Halogenated Compounds from LC‑MS Profiles–Application to the Isolation of Bioactive Chlorinated Compounds from Marine-Derived Fungi by Roullier, Catherine, Guitton, Yann, Valery, Marine, Amand, Séverine, Prado, Soizic, Robiou du Pont, Thibaut, Grovel, Olivier, Pouchus, Yves François

“…A collection of culture extracts obtained from several marine-derived fungal strains collected on the French Atlantic coast was investigated by high…”
Get full text

Targetable Molecular Alterations in the Treatment of Biliary Tract Cancers: An Overview of the Available Treatments by Valery, Marine, Vasseur, Damien, Fachinetti, Francesco, Boilève, Alice, Smolenschi, Cristina, Tarabay, Anthony, Antoun, Leony, Perret, Audrey, Fuerea, Alina, Pudlarz, Thomas, Boige, Valérie, Hollebecque, Antoine, Ducreux, Michel

“…Biliary tract cancers (BTCs) are rare tumours, most often diagnosed at an unresectable stage, associated with poor prognosis, with a 5-year survival rate not…”
Get full text

Immunotherapy and Hepatocellular Cancer: Where Are We Now? by Valery, Marine, Cervantes, Baptiste, Samaha, Ramy, Gelli, Maximiliano, Smolenschi, Cristina, Fuerea, Alina, Tselikas, Lambros, Klotz-Prieux, Caroline, Hollebecque, Antoine, Boige, Valérie, Ducreux, Michel

“…Immunotherapy has demonstrated its effectiveness in many cancers. In hepatocellular carcinoma (HCC), promising results shown in the first phase II studies…”
Get full text

Precision Medicine in Pancreatic Ductal Adenocarcinoma: The Impact of Targeted Therapies on Survival of Patients Harboring Actionable Mutations by Tarabay, Anthony, Boileve, Alice, Smolenschi, Cristina, Antoun, Leony, Valery, Marine, Fuerea, Alina, Perret, Audrey, Burtin, Pascal, Cosconea, Simona, Belkhodja, Hichem, Malka, David, Boige, Valérie, Hollebecque, Antoine, Ducreux, Michel

“…Background: Pancreatic ductal adenocarcinoma (PDAC) is the third leading cause of death by cancer worldwide. Mostly diagnosed with locally advanced or…”
Get full text

Abstract A101: Codon-specific KRAS mutations predict survival in advanced pancreatic cancer by Boilève, Alice, Rousseau, Adrien, Hilmi, Marc, Tarabay, Anthony, Mathieu, Jacques R.R., Goudarzi, Negaar, Cartry, Jérôme, Bedja, Sabrina, Nicotra, Claudio, NgoCamus, Maud, Boige, Valérie, Valéry, Marine, Bani, Mohamed Amine, Tselikas, Lambros, Italiano, Antoine, Jaulin, Fanny, Smolenschi, Cristina, Hollebecque, Antoine, Ducreux, Michel

“…Abstract Background: How distinct KRAS alterations in pancreatic adenocarcinoma (PDAC) influence tumor initiation and outcomes remains unclear. Moreover, KRAS…”
Get full text

Mutations de l'ADN dans les cholangiocarcinomes : cibler IDH1 et autres mutations by Valéry, Marine, Cervantes, Baptiste, Smolenschi, Cristina, Boige, Valérie, Ducreux, Michel, Cohen, Romain, Hollebecque, Antoine

“…Les cancers des voies biliaires (CVB) sont des cancers rares et de mauvais pronostic, en particulier au stade métastatique avec moins de 7 % de survie à 5 ans…”
Get full text

Cholangiocarcinoma with STRN-ALK translocation treated with ALK inhibitors by Valery, Marine, Facchinetti, Francesco, Malka, David, Ducreux, Michel, Friboulet, Luc, Hollebecque, Antoine

Get full text

Precision medicine for KRAS wild-type pancreatic adenocarcinomas by Ben-Ammar, Imen, Rousseau, Adrien, Nicolle, Rémy, Tarabay, Anthony, Boige, Valérie, Valery, Marine, Pudlarz, Thomas, Malka, David, Gelli, Maximiliano, Fernandez-De-Sevilla, Elena, Fuerea, Alina, Tanguy, Marie-Laure, Rouleau, Etienne, Barbe, Rémy, Mathieu, Jacques R R, Jaulin, Fanny, Smolenschi, Cristina, Hollebecque, Antoine, Ducreux, Michel, Boileve, Alice

“…KRAS mutation is the most common molecular alteration in pancreatic adenocarcinoma (PDAC), and around 10% of patients harbor KRAS wild-type tumors (KRAS ). A…”
Get full text

Oxaliplatin in metastatic colorectal cancer: Does hepatic arterial infusion reduce sensitive neuropathy compared to the intravenous route? by Valery, Marine, Tanguy, Marie Laure, Boige, Valérie, Smolenschi, Cristina, Hollebecque, Antoine, Fuerea, Alina, Klotz-Prieux, Caroline, Benhaim, Leonor, Debaere, Thierry, Gelli, Maximiliano, Tselikas, Lambros, Ducreux, Michel, Malka, David

“…Abstract only 95 Background: Oxaliplatin, a major drug in metastatic colorectal cancer (MCRC), is responsible for a cumulative and limiting peripheral…”
Get full text

Is liquid biopsy useful in patients with GI malignancies and exclusive peritoneal disease? by Smolenschi, Cristina, Valery, Marine, Boileve, Alice, Cervantes, Baptiste, Tarabay, Anthony, Boige, Valerie, Ben-Ammar, Imen, Cheaib, Bianca, Gelli, Maximiliano, Sourouille, Isabelle, Benhaim, Leonor, Fuerea, Alina, Perret, Audrey, Ducreux, Michel, Hollebecque, Antoine

“…809 Background: Peritoneal carcinomatosis (PC) is a common manifestation in gastro-intestinal (GI) cancers.10-20 % of patients (pts) will present isolated,…”
Get full text

KRAS WT pancreatic adenocarcinomas: Another disease? by Ben-Ammar, Imen, Ducreux, Michel, Boige, Valérie, Hollebecque, Antoine, Tarabay, Anthony, Smolenschi, Cristina, Gelli, Maximiliano, Tanguy, Marie Laure, Valery, Marine, Rouleau, Etienne, Barbe, Rémy, Boileve, Alice, Fuerea, Alina Cristina

“…750 Background: KRAS mutation is the most common molecular alteration (MA) in pancreatic adenocarcinoma (PDAC), and only 8-10% of patients (pts) harbor KRAS…”
Get full text

Immunotherapy: Auto-immune toxicity as a predictive factor of response by Valery, Marine, Vallet, Emilie, Lassoued, Donia, Maingon, Philippe, Tilleul, Patrick, Spano, Jean-Philippe, Bellanger, Agnes, Gobert, Aurelien

“…Abstract only e14086 Background: PD-1 and PD-L1 inhibitors have now demonstrated their efficacy. Finding predictive or pre-emptive response factors is crucial…”
Get full text

Role of molecular biology in the management of pancreatic cancer by Boileve, Alice, Smolenschi, Cristina, Lambert, Aurélien, Boige, Valérie, Tarabay, Anthony, Valery, Marine, Fuerea, Alina, Pudlarz, Thomas, Conroy, Thierry, Hollebecque, Antoine, Ducreux, Michel

“…Pancreatic ductal adenocarcinoma (PDAC) presents significant challenges in patient management due to a dismal prognosis, increasing incidence, and limited…”
Get full text

Cholangiocarcinoma with STRN-ALK translocation treated with ALK inhibitors by Valery, Marine, Facchinetti, Francesco, Malka, David, Ducreux, Michel, Friboulet, Luc, Hollebecque, Antoine

Get full text